source
- Akeso CEO says biliary tract cancer data could be a breakthroughAkeso’s chief executive Michelle Xia told ChinaPharma that the company’s PD-1xVEGF bispecific antibody, ivonescimab, is generating strong interest after early biliary tract cancer results. She not…
- DEA moves on kratom substances as FDA greenlights new pancreatic drugThe Drug Enforcement Administration is taking new steps concerning substances associated with kratom, signaling a shift in how the agency handles the plant-derived compounds. In a separate develop…